Lamotrigine for cognitive deficits associated with neurofibromatosis type 1: A phase II randomized placebo-controlled trial
Dev Med Child Neurol. 2024 Sep 28. doi: 10.1111/dmcn.16094. Online ahead of print. ABSTRACT AIM: To find proof-of-principle evidence for short-term treatment with lamotrigine to …